Spire Wealth Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-130
Closed -$2.26K 2247
2024
Q2
$2.26K Sell
130
-25
-16% -$443 ﹤0.01% 1988
2024
Q1
$3.04K Buy
155
+64
+70% +$1.35K ﹤0.01% 2022
2023
Q4
$1.9K Hold
91
﹤0.01% 2153
2023
Q3
$2.09K Hold
91
﹤0.01% 2131
2023
Q2
$2.38K Buy
+91
New +$2.4K ﹤0.01% 2168
2023
Q1
Sell
-12,000
Closed -$273K 2573
2022
Q4
$273K Buy
12,000
+11,500
+2,300% +$320K 0.02% 482
2022
Q3
$17K Hold
500
﹤0.01% 1390
2022
Q2
$15K Buy
+500
New +$12.7K ﹤0.01% 1780

Other funds holding PRVA

Spire Wealth Management's PRVA Position: Q3 2024 in Review

Spire Wealth Management sold out of Privia Health (PRVA) in Q3 2024, closing a stake of 130 shares — an estimated $2.26K sold.

Spire Wealth Management first reported a position in PRVA in Q2 2022 and held it in 8 quarters. The position peaked at $273K in Q4 2022. 234 funds tracked by Wall St. Rank hold PRVA as of Q3 2024.

  • Spire Wealth Management reported no remaining Privia Health position as of Q3 2024 after selling out during the quarter.
  • Spire Wealth Management sold 130 Privia Health shares in Q3 2024, an estimated $2.26K.
  • Spire Wealth Management first reported a position in Privia Health in Q2 2022 and held it in 8 quarters.
  • Spire Wealth Management's Privia Health position peaked at $273K in Q4 2022.
  • 234 funds tracked by Wall St. Rank held Privia Health as of Q3 2024.

Based on Spire Wealth Management's 13F filing for Q3 2024, filed 15 Oct 2024.